speb/financial-data huggingface dataset:
Financial ratios for NOCIL.NS — quarterly report dated 2025-12-31
Total revenue: 35183246.07329843
Gross profit: 14695332.516430879
Operating income: 1441461.512754818
Net income: 1030411.0504622926
Capital expenditures: 0
Depreciation & amortization: 1546173.5546396347
Owner earnings: 2576584.605101927
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.7157179458616467
P/E ratio: 41.03095075970609
Shares outstanding: 167024930
Market cap (USD): 286567669.8072853
Effective tax rate (%): 31.021625652498138
Interest coverage ratio: 38.05882352941177
COGS to revenue (%): 58.232016210739616
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -10.57164328641712
Rule of 40 score: -10.57164328641712
Financial ratios for ORA.PA — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 9817045454.545454
Buffett classification: The Gruesome
Stock price: 8.068181818181818
Shares outstanding: 2657769336
Market cap (USD): 21443366233.636364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORA.PA — annual report dated 2022-12-31
Total revenue: 41625531914.893616
Gross profit: 24429787234.042553
Operating income: 5931914893.617022
Net income: 2784042553.1914897
Capital expenditures: 8811702127.659575
Operating cash flow: 11952127659.574469
Depreciation & amortization: 9201063829.787235
Net tangible assets: -6675531914.893618
Owner earnings: 3173404255.319151
Return on net tangible assets (%): -47.537848605577715
Capex to operating income (%): 148.5473457675753
Buffett classification: The Gruesome
Stock price: 7.968085106382979
P/E ratio: 7.606684114115399
Shares outstanding: 2657769336
Book value: 37187234042.55319
P/B ratio: 0.569478553800206
Market cap (USD): 21177332262.38298
Debt to equity: 0.9157798375100127
Current ratio: 0.9171913495756912
Quick ratio: 0.8813304133588831
Effective tax rate (%): 33.7966537966538
Interest coverage ratio: 6.188679245283018
COGS to revenue (%): 41.31057043549377
SG&A to revenue (%): 22.796974033939893
Free cash flow (dilution-adjusted): 2600000000.0000005
Buyback yield (%): 0
Retained earnings: -708510638.2978724
Inventory turnover: 15.423664122137405
Receivables turnover: 4.212294111314458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.933081341854624
FCF margin (%): 6.246166428133307
Rule of 40 score: 6.246166428133307
Financial ratios for ORA.PA — annual report dated 2023-12-31
Total revenue: 44085555555.55556
Gross profit: 25461111111.11111
Operating income: 5721111111.111111
Net income: 3213333333.3333335
Capital expenditures: 8495555555.555555
Operating cash flow: 13393333333.333332
Depreciation & amortization: 9958888888.88889
Net tangible assets: -7832222222.222222
Owner earnings: 4676666666.666668
Return on net tangible assets (%): -59.71059724783658
Capex to operating income (%): 148.49485336958634
Buffett classification: The Gruesome
Stock price: 9.844444444444443
P/E ratio: 8.142405365477176
Shares outstanding: 2657769336
Book value: 38998888888.888885
P/B ratio: 0.6708976414416364
Market cap (USD): 26164262574.399998
Debt to equity: 0.24410951878970913
Current ratio: 0.8268147274633123
Quick ratio: 0.7890788784067085
Effective tax rate (%): 24.551066217732885
Interest coverage ratio: 3.9516500383729856
COGS to revenue (%): 42.24613756080348
SG&A to revenue (%): 22.728532903193287
Free cash flow (dilution-adjusted): 4528888888.888889
Buyback yield (%): 0
Retained earnings: -694444444.4444444
Inventory turnover: 14.550347222222221
Receivables turnover: 3.1797563712133354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.474774910718777
FCF margin (%): 10.272954104392975
Revenue growth (%): 5.909891183352651
Rule of 40 score: 16.182845287745625
Financial ratios for ORA.PA — annual report dated 2024-12-31
Total revenue: 41936458333.333336
Gross profit: 24593750000
Operating income: 6277083333.333334
Net income: 3022916666.666667
Capital expenditures: 7039583333.333334
Operating cash flow: 10619791666.666668
Depreciation & amortization: 8263541666.666667
Net tangible assets: -1858333333.3333335
Owner earnings: 4246875000
Return on net tangible assets (%): -228.53139013452912
Capex to operating income (%): 112.14736143378691
Buffett classification: The Gruesome
Stock price: 9.250000000000002
P/E ratio: 8.132664267291524
Shares outstanding: 2657769336
Book value: 36626041666.66667
P/B ratio: 0.6712264072034356
Market cap (USD): 24584366358.000004
Debt to equity: 0.20949347288188616
Current ratio: 0.920808399326334
Quick ratio: 0.8924642562797865
Effective tax rate (%): 33.46505309953075
Interest coverage ratio: 4.592987804878049
COGS to revenue (%): 41.35472813532378
SG&A to revenue (%): -21.008966939069527
Free cash flow (dilution-adjusted): 3280208333.3333335
Buyback yield (%): 0
Retained earnings: -704166666.6666667
Inventory turnover: 21.048040455120102
Receivables turnover: 6.896026036313806
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.932391696394488
FCF margin (%): 7.821853498596587
Revenue growth (%): -4.874833026690524
Rule of 40 score: 2.947020471906063
Financial ratios for ORA.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.250000000000002
Shares outstanding: 2657769336
Market cap (USD): 24584366358.000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORA.PA — quarterly report dated 2025-03-31
Total revenue: 10772826086.956522
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.021739130434783
Shares outstanding: 2657769336
Market cap (USD): 31951009626.26087
COGS to revenue (%): 0
SG&A to revenue (%): -37.72575925739077
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORA.PA — quarterly report dated 2025-06-30
Total revenue: 11696470588.235294
Capital expenditures: 0
Net tangible assets: -4807058823.529412
Buffett classification: The Gruesome
Stock price: 14.505882352941176
Shares outstanding: 2657769336
Book value: 38378823529.41176
P/B ratio: 1.0045458866065846
Market cap (USD): 38553289309.27059
Debt to equity: 0.2301514315492613
Current ratio: 0.8911427397362621
Quick ratio: 0.8608838581941799
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: -3036470588.2352943
Inventory turnover: 0
Receivables turnover: 1.8441847523650527
Capitalized R&D asset: 0
Revenue growth (%): 8.5738365571231
Rule of 40 score: 8.5738365571231
Financial ratios for ORA.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.505882352941176
Shares outstanding: 2657769336
Market cap (USD): 41211058645.27059
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORA.PA — annual report dated 2025-12-31
Total revenue: 47525882352.94118
Gross profit: 28245882352.941177
Operating income: 4894117647.058824
Net income: 1340000000
Capital expenditures: 8214117647.058824
Operating cash flow: 12682352941.176472
Depreciation & amortization: 10058823529.411764
Net tangible assets: -4149411764.7058825
Owner earnings: 3184705882.3529406
Return on net tangible assets (%): -76.75077969946128
Capex to operating income (%): 167.83653846153845
Buffett classification: The Gruesome
Stock price: 16.294117647058822
P/E ratio: 32.31791510412642
Shares outstanding: 2657769336
Book value: 39005882352.94118
P/B ratio: 1.11024295893832
Market cap (USD): 43306006239.52941
Debt to equity: 0.2268737746946162
Current ratio: 1.11416123684312
Quick ratio: 1.085514901492077
Effective tax rate (%): 49.37701892016612
Interest coverage ratio: 3.1021625652498135
COGS to revenue (%): 40.56736886402456
SG&A to revenue (%): -24.3582444240909
Free cash flow (dilution-adjusted): 3876470588.2352943
Buyback yield (%): 0
Retained earnings: -2660000000
Inventory turnover: 22.056527590847914
Receivables turnover: 7.821297192642787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.105672696924322
FCF margin (%): 8.156546278188975
Revenue growth (%): 13.328316795805975
Rule of 40 score: 21.48486307399495
Financial ratios for ORA.PA — quarterly report dated 2025-12-31
Total revenue: 12411764705.882353
Capital expenditures: 0
Net tangible assets: -4149411764.7058825
Buffett classification: The Gruesome
Stock price: 16.294117647058822
Shares outstanding: 2657769336
Book value: 39005882352.94118
P/B ratio: 1.11024295893832
Market cap (USD): 43306006239.52941
Debt to equity: 0.2268737746946162
Current ratio: 1.11416123684312
Quick ratio: 1.085514901492077
COGS to revenue (%): 0
SG&A to revenue (%): -18.748815165876778
Buyback yield (%): 0
Retained earnings: -2660000000
Inventory turnover: 0
Receivables turnover: 2.0425943852855757
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORCA.L — annual report dated 2022-06-30
Total revenue: 0
Operating income: -1307052.4390243904
Net income: -1935032.9268292685
Capital expenditures: 1647467.0731707318
Operating cash flow: -1614434.1463414636
Depreciation & amortization: 821.9512195121952
Net tangible assets: 3810230.4878048785
Owner earnings: -3581678.048780488
Return on net tangible assets (%): -94.00161119502084
Buffett classification: The Gruesome
Stock price: 0.004390243902439025
Shares outstanding: 79205343
Book value: 3810230.4878048785
P/B ratio: 0.09126239876020559
Market cap (USD): 347730.7741463415
Debt to equity: 0.3060387166898872
Current ratio: 2.3979158423801596
Quick ratio: 2.3979158423801596
Interest coverage ratio: -25.598485753182548
Free cash flow (dilution-adjusted): -3261901.2195121953
Buyback yield (%): 0
Retained earnings: -2081471.9512195124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.265502418410357
Rule of 40 score: 0
Financial ratios for ORCA.L — annual report dated 2023-06-30
Total revenue: 0
Operating income: -902931.6455696202
Net income: -1499941.7721518986
Capital expenditures: 1267789.8734177214
Operating cash flow: -757163.2911392405
Depreciation & amortization: 2306.3291139240505
Net tangible assets: 3130930.379746835
Owner earnings: -2765425.316455696
Return on net tangible assets (%): -88.32599199089525
Buffett classification: The Gruesome
Stock price: 0.0003797468354430379
Shares outstanding: 79205343
Book value: 3130930.3797468357
P/B ratio: 0.00960672218999084
Market cap (USD): 30077.978354430375
Debt to equity: 0.4007944417379069
Current ratio: 0.10169099045009262
Quick ratio: 0.10169099045009262
Interest coverage ratio: -8.915669878885597
Free cash flow (dilution-adjusted): -2024953.164556962
Buyback yield (%): 0
Retained earnings: -3660456.9620253164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.83908410772872
Rule of 40 score: 0
Financial ratios for ORCA.L — annual report dated 2024-06-30
Total revenue: 0
Operating income: -753429.1139240506
Net income: -1187937.9746835444
Capital expenditures: 647605.0632911392
Operating cash flow: -619983.5443037974
Depreciation & amortization: 2220.253164556962
Net tangible assets: 2918308.8607594934
Owner earnings: -1833322.7848101265
Return on net tangible assets (%): -62.82141035383767
Buffett classification: The Gruesome
Stock price: 0.0011392405063291138
Shares outstanding: 79205343
Book value: 2918308.860759494
P/B ratio: 0.030919940064125913
Market cap (USD): 90233.93506329112
Debt to equity: 0.47525313776315736
Current ratio: 0.09996397648398532
Quick ratio: 0.09996397648398532
Interest coverage ratio: -5.662186073059361
Free cash flow (dilution-adjusted): -1267588.6075949366
Buyback yield (%): 0
Retained earnings: -4848394.93670886
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.817319203422823
Rule of 40 score: 0
Financial ratios for ORCA.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 2282873.75
Buffett classification: The Gruesome
Stock price: 0.00125
Shares outstanding: 79205343
Book value: 2320561.25
P/B ratio: 0.042664971135754334
Market cap (USD): 99006.67875
Debt to equity: 0.6734356828547404
Current ratio: 0.03221346917189234
Quick ratio: 0.03221346917189234
Buyback yield (%): 0
Retained earnings: -5330308.75
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORCA.L — annual report dated 2025-06-30
Total revenue: 0
Operating income: -1259973.9726027397
Net income: -1212200
Capital expenditures: 166612.32876712328
Operating cash flow: -119090.41095890412
Depreciation & amortization: 1435.6164383561645
Net tangible assets: 1945969.8630136987
Owner earnings: -1377376.712328767
Return on net tangible assets (%): -70.78098887901795
Buffett classification: The Gruesome
Stock price: 0.0015068493150684932
Shares outstanding: 79205343
Book value: 1945969.8630136987
P/B ratio: 0.061332150676001965
Market cap (USD): 119350.51684931507
Debt to equity: 0.8275783178159568
Current ratio: 0.05944806160014194
Quick ratio: 0.05944806160014194
Interest coverage ratio: -7.0509938902389475
Free cash flow (dilution-adjusted): -285702.7397260274
Buyback yield (%): 0
Retained earnings: -6438545.205479452
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.74786668337372
Rule of 40 score: 0
Financial ratios for ORCA.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1945969.8630136987
Buffett classification: The Gruesome
Stock price: 0.0015068493150684932
Shares outstanding: 79205343
Book value: 1945969.8630136987
P/B ratio: 0.061332150676001965
Market cap (USD): 119350.51684931507
Debt to equity: 0.8275783178159568
Current ratio: 0.05944806160014194
Quick ratio: 0.05944806160014194
Buyback yield (%): 0
Retained earnings: -6438545.205479452
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORCL — annual report dated 2021-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 73.34
Shares outstanding: 2880471000
Market cap (USD): 211253743140
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORCL — annual report dated 2022-05-31
Total revenue: 42440000000
Gross profit: 33563000000
Operating income: 15830000000
Net income: 6717000000
Capital expenditures: 4511000000
Operating cash flow: 9539000000
Depreciation & amortization: 3122000000
Net tangible assets: -51471000000
Owner earnings: 5328000000
Return on net tangible assets (%): -10.351460045462494
Capex to operating income (%): 28.496525584333543
Buffett classification: The Good
Stock price: 67.98
P/E ratio: 29.15206469852613
Shares outstanding: 2880471000
Book value: -5768000000
Market cap (USD): 195814418580
Debt to equity: -13.151699029126213
Current ratio: 1.6212905540464353
Quick ratio: 1.6212905540464353
Effective tax rate (%): 12.184599294025363
Interest coverage ratio: 5.745916515426497
COGS to revenue (%): 20.916588124410936
R&D to revenue (%): 17.00989632422243
SG&A to revenue (%): 22.064090480678605
Free cash flow (dilution-adjusted): 2415000000
Buyback yield (%): 8.855834072767902
Retained earnings: -31336000000
Receivables turnover: 7.1291785654291955
Capitalized R&D asset: 7219000000
ROCI (R&D-adjusted, %): 21.280002748999195
FCF margin (%): 5.6903864278982095
Rule of 40 score: 5.6903864278982095
Financial ratios for ORCL — annual report dated 2023-05-31
Total revenue: 49954000000
Gross profit: 36390000000
Operating income: 13773000000
Net income: 8503000000
Capital expenditures: 8695000000
Operating cash flow: 17165000000
Depreciation & amortization: 6108000000
Net tangible assets: -71025000000
Owner earnings: 5916000000
Return on net tangible assets (%): -8.329461457233368
Capex to operating income (%): 63.13076308719959
Buffett classification: The Good
Stock price: 101.91
P/E ratio: 34.52296831824062
Shares outstanding: 2880471000
Book value: 1556000000
P/B ratio: 188.6560408804627
Market cap (USD): 293548799610
Debt to equity: 58.14974293059126
Current ratio: 0.9096578605456908
Quick ratio: 0.9096578605456908
Effective tax rate (%): 6.826649134341442
Interest coverage ratio: 3.9295292439372327
COGS to revenue (%): 27.1529807422829
R&D to revenue (%): 17.26188093045602
SG&A to revenue (%): 20.843175721663933
Free cash flow (dilution-adjusted): 4923000000
Buyback yield (%): 0.8526691314443832
Retained earnings: -27620000000
Receivables turnover: 7.224005784526392
Capitalized R&D asset: 13459730000
ROCI (R&D-adjusted, %): 13.719295874627022
Rosenberg metric: 0.39160548552431085
FCF margin (%): 9.855066661328422
Revenue growth (%): 17.704995287464655
Rule of 40 score: 27.560061948793077
Financial ratios for ORCL — annual report dated 2024-05-31
Total revenue: 52961000000
Gross profit: 37818000000
Operating income: 16071000000
Net income: 10467000000
Capital expenditures: 6866000000
Operating cash flow: 18673000000
Depreciation & amortization: 6139000000
Net tangible assets: -60416000000
Owner earnings: 9740000000
Return on net tangible assets (%): -16.12155720338983
Capex to operating income (%): 42.72291705556593
Buffett classification: The Good
Stock price: 114.35
P/E ratio: 31.46860216394382
Shares outstanding: 2880471000
Book value: 9239000000
P/B ratio: 35.651245681350794
Market cap (USD): 329381858850
Debt to equity: 10.079445827470506
Current ratio: 0.7150012680699974
Quick ratio: 0.7150012680699974
Effective tax rate (%): 10.850864491951281
Interest coverage ratio: 4.573420603301082
COGS to revenue (%): 28.59273805252922
R&D to revenue (%): 16.833141368176584
SG&A to revenue (%): 18.545722323974246
Free cash flow (dilution-adjusted): 7833000000
Buyback yield (%): 0.9842679288164445
Retained earnings: -22628000000
Receivables turnover: 6.726060452120905
Capitalized R&D asset: 17074680000
ROCI (R&D-adjusted, %): 13.227496497945143
Rosenberg metric: 0.16560361823031428
FCF margin (%): 14.790128585185325
Revenue growth (%): 6.019537974936942
Rule of 40 score: 20.809666560122267
Financial ratios for ORCL — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 138.25
Shares outstanding: 2880471000
Market cap (USD): 398225115750
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORCL — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 181.27
Shares outstanding: 2880471000
Market cap (USD): 522142978170
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORCL — quarterly report dated 2025-02-28
Total revenue: 14130000000
Gross profit: 9935000000
Operating income: 4449000000
Net income: 2936000000
Capital expenditures: 5862000000
Operating cash flow: 5933000000
Depreciation & amortization: 1551000000
Net tangible assets: -50572000000
Owner earnings: -1375000000
Capex to operating income (%): 131.75994605529334
Buffett classification: The Gruesome
Stock price: 163.25
P/E ratio: 40.04060718239101
Shares outstanding: 2880471000
Book value: 17261000000
P/B ratio: 27.242737428306587
Market cap (USD): 470236890750
Debt to equity: 5.577660622211923
Current ratio: 1.0166424737535023
Quick ratio: 1.0166424737535023
Effective tax rate (%): 14.849187935034802
Interest coverage ratio: 4.987668161434978
COGS to revenue (%): 29.688605803255484
R&D to revenue (%): 17.19037508846426
SG&A to revenue (%): 17.75654635527247
Free cash flow (dilution-adjusted): -1127000000
Buyback yield (%): 0.032324133429337924
Retained earnings: -17368000000
Receivables turnover: 1.7550614830455844
Capitalized R&D asset: 2429000000
ROCI (R&D-adjusted, %): 4.52239710646078
FCF margin (%): -7.975937721160651
Rule of 40 score: -7.975937721160651
Financial ratios for ORCL — quarterly report dated 2025-05-31
Total revenue: 15903000000
Gross profit: 11162000000
Operating income: 5191000000
Net income: 3427000000
Capital expenditures: 9080000000
Operating cash flow: 6157000000
Depreciation & amortization: 1696000000
Net tangible assets: -41756000000
Owner earnings: -3957000000
Capex to operating income (%): 174.91812752841454
Buffett classification: The Gruesome
Stock price: 163.32
P/E ratio: 73.93344707213578
Shares outstanding: 2880471000
Book value: 20969000000
P/B ratio: 22.434952726405644
Market cap (USD): 470438523720
Debt to equity: 4.964662120272783
Current ratio: 0.7529638819961401
Quick ratio: 0.7529638819961401
Effective tax rate (%): 17.46146435452794
Interest coverage ratio: 5.307770961145194
COGS to revenue (%): 29.8119851600327
R&D to revenue (%): 16.688675092749797
SG&A to revenue (%): 17.43696157957618
Free cash flow (dilution-adjusted): -4223000000
Buyback yield (%): 0.03188514384703715
Retained earnings: -15481000000
Receivables turnover: 1.858261275999065
Capitalized R&D asset: 4281430000
ROCI (R&D-adjusted, %): 4.393351220549017
Rosenberg metric: 0.5051461506792919
FCF margin (%): -26.55473809972961
Revenue growth (%): 12.547770700636942
Rule of 40 score: -14.00696739909267
Financial ratios for ORCL — annual report dated 2025-05-31
Total revenue: 57399000000
Gross profit: 40472000000
Operating income: 18052000000
Net income: 12443000000
Capital expenditures: 21215000000
Operating cash flow: 20821000000
Depreciation & amortization: 6174000000
Net tangible assets: -41756000000
Owner earnings: -2598000000
Capex to operating income (%): 117.52160425437626
Buffett classification: The Gruesome
Stock price: 163.32
P/E ratio: 37.807484024752874
Shares outstanding: 2880471000
Book value: 20969000000
P/B ratio: 22.434952726405644
Market cap (USD): 470438523720
Debt to equity: 4.964662120272783
Current ratio: 0.7529638819961401
Quick ratio: 0.7529638819961401
Effective tax rate (%): 12.125706214689265
Interest coverage ratio: 5.045276690888764
COGS to revenue (%): 29.490060802453005
R&D to revenue (%): 17.17799961671806
SG&A to revenue (%): 17.862680534504086
Free cash flow (dilution-adjusted): -5068000000
Buyback yield (%): 0.31885143847037156
Retained earnings: -15481000000
Receivables turnover: 6.707057723767235
Capitalized R&D asset: 18678640000
ROCI (R&D-adjusted, %): 12.163045344337373
Rosenberg metric: 0.2977005047672462
FCF margin (%): -8.829422115367864
Revenue growth (%): 8.379751137629576
Rule of 40 score: -0.4496709777382879
Financial ratios for ORCL — quarterly report dated 2025-08-31
Total revenue: 14926000000
Gross profit: 10042000000
Operating income: 4692000000
Net income: 2927000000
Capital expenditures: 8502000000
Operating cash flow: 8140000000
Depreciation & amortization: 1771000000
Net tangible assets: -42224000000
Owner earnings: -3804000000
Capex to operating income (%): 181.20204603580564
Buffett classification: The Gruesome
Stock price: 223.58
P/E ratio: 69.32354210764264
Shares outstanding: 2880471000
Book value: 24666000000
P/B ratio: 26.10945050595962
Market cap (USD): 644015706180
Debt to equity: 4.273453336576664
Current ratio: 0.6177960575813813
Quick ratio: 0.6177960575813813
Effective tax rate (%): 14.590020426028596
Interest coverage ratio: 5.083423618634886
COGS to revenue (%): 32.72142570012059
R&D to revenue (%): 16.688999062039393
SG&A to revenue (%): 16.340613694224842
Free cash flow (dilution-adjusted): -1486000000
Buyback yield (%): 0.01739088021072213
Retained earnings: -14054000000
Receivables turnover: 1.6878887255456294
Capitalized R&D asset: 5070750000
ROCI (R&D-adjusted, %): 3.198399770218722
Rosenberg metric: -0.42200452147701584
FCF margin (%): -9.955781857162
Revenue growth (%): -6.143494938062001
Rule of 40 score: -16.099276795224
Financial ratios for ORCL — quarterly report dated 2025-11-30
Total revenue: 16058000000
Gross profit: 10684000000
Operating income: 5158000000
Net income: 6135000000
Capital expenditures: 12033000000
Operating cash flow: 2066000000
Depreciation & amortization: 2110000000
Net tangible assets: -36016000000
Owner earnings: -3788000000
Capex to operating income (%): 233.2880961613028
Buffett classification: The Gruesome
Stock price: 200.02
P/E ratio: 37.35181908719611
Shares outstanding: 2880471000
Book value: 30457000000
P/B ratio: 18.91689297764061
Market cap (USD): 576151809420
Debt to equity: 4.0839872607282395
Current ratio: 0.9092737134541606
Quick ratio: 0.9092737134541606
Effective tax rate (%): 3.2639545884578998
Interest coverage ratio: 4.879848628192999
COGS to revenue (%): 33.466185079088305
R&D to revenue (%): 15.948436916178851
SG&A to revenue (%): 15.929754639432058
Free cash flow (dilution-adjusted): -11123000000
Buyback yield (%): 0.01596801372412845
Retained earnings: -9355000000
Receivables turnover: 1.7010593220338983
Capitalized R&D asset: 5105790000
ROCI (R&D-adjusted, %): 2.9892565720259645
Rosenberg metric: 0.2577278201525492
FCF margin (%): -69.26765475152573
Revenue growth (%): 7.58408146857832
Rule of 40 score: -61.68357328294741
Financial ratios for P4O.DE — annual report dated 2021-12-31
Total revenue: 10757726.375000002
Gross profit: 9376196.772727273
Operating income: 1260103.6931818181
Net income: 783011.4772727273
Capital expenditures: 1461363.6363636365
Operating cash flow: 1462500
Depreciation & amortization: 735497.3068181818
Net tangible assets: 8835416.386363637
Owner earnings: 57145.147727272706
Return on net tangible assets (%): 0.6467736802474767
Capex to operating income (%): 115.97169695405209
Buffett classification: The Gruesome
Stock price: 2.931818181818182
P/E ratio: 16.91340368428943
Shares outstanding: 4517125
Book value: 9212455.022727273
P/B ratio: 1.437552657991144
Market cap (USD): 13243389.204545455
Debt to equity: 0.5099449270531901
Current ratio: 9.761516934485154
Quick ratio: 5.377180971050385
Effective tax rate (%): 34.08908430261727
Interest coverage ratio: 17.472465562552756
COGS to revenue (%): 12.842208047634292
Free cash flow (dilution-adjusted): 1136.3636363636363
Buyback yield (%): 0
Retained earnings: 3385594.022727273
Inventory turnover: 0.3042374733357479
Receivables turnover: 28.3170150642716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.395503375611046
FCF margin (%): 0.0105632323852784
Rule of 40 score: 0.0105632323852784
Financial ratios for P4O.DE — annual report dated 2022-12-31
Total revenue: 12197564.734042553
Gross profit: 10617818.382978722
Operating income: 2137231.3191489363
Net income: 1461042.0638297873
Capital expenditures: 1018085.1063829787
Operating cash flow: 539361.7021276596
Depreciation & amortization: 753191.4893617021
Net tangible assets: 9661856.340425534
Owner earnings: 1196148.446808511
Return on net tangible assets (%): 12.380110039556119
Capex to operating income (%): 47.6357003222463
Buffett classification: The Good
Stock price: 3.5106382978723403
P/E ratio: 10.8538914887286
Shares outstanding: 4517125
Book value: 10085468.042553194
P/B ratio: 1.5723605443364288
Market cap (USD): 15857992.021276595
Debt to equity: 0.3693896669081052
Current ratio: 11.923311188806604
Quick ratio: 5.252930575824379
Effective tax rate (%): 31.146685463657576
Interest coverage ratio: 33.7827522434702
COGS to revenue (%): 12.951325822070597
Free cash flow (dilution-adjusted): -604255.3191489362
Buyback yield (%): 0
Retained earnings: 4630534.340425532
Inventory turnover: 0.28348967579480205
Receivables turnover: 45.63635019398724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.107668183867675
FCF margin (%): -4.953901310009052
Revenue growth (%): 13.384225521747862
Rule of 40 score: 8.43032421173881
Financial ratios for P4O.DE — annual report dated 2023-12-31
Total revenue: 14725588.322222222
Gross profit: 12517428.47777778
Operating income: 2622890.3777777776
Net income: 1854644.1222222222
Capital expenditures: 894444.4444444444
Operating cash flow: 2977777.7777777775
Depreciation & amortization: 837777.7777777778
Net tangible assets: 12986036.299999999
Owner earnings: 1797977.4555555554
Return on net tangible assets (%): 13.84546765478821
Capex to operating income (%): 34.10148026095757
Buffett classification: The Good
Stock price: 3.422222222222222
P/E ratio: 8.335079150944148
Shares outstanding: 4517125
Book value: 13430021.855555557
P/B ratio: 1.1510484287976672
Market cap (USD): 15458605.555555554
Debt to equity: 0.2108305975810495
Current ratio: 29.359137585877622
Quick ratio: 15.039402770365479
Effective tax rate (%): 28.00767518590081
Interest coverage ratio: 59.597103510713254
COGS to revenue (%): 14.995393026926706
Free cash flow (dilution-adjusted): 2083333.3333333333
Buyback yield (%): 0
Retained earnings: 6690979.988888889
Inventory turnover: 0.3716718996197042
Receivables turnover: 23.063305299637488
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.902000646046748
FCF margin (%): 14.147708653442375
Revenue growth (%): 20.725641907225388
Rule of 40 score: 34.87335056066776
Financial ratios for P4O.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 12970833.333333334
Buffett classification: The Gruesome
Stock price: 3.3333333333333335
Shares outstanding: 4517125
Book value: 13282291.666666666
P/B ratio: 1.1336208924790214
Market cap (USD): 15057083.333333334
Debt to equity: 0.38655791702611564
Current ratio: 3.5814249363867687
Quick ratio: 2.01940203562341
Buyback yield (%): 0
Retained earnings: 6964583.333333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for P4O.DE — annual report dated 2024-12-31
Total revenue: 12352083.333333334
Gross profit: 10538541.666666668
Operating income: 1055208.3333333335
Net income: 707291.6666666667
Capital expenditures: 400000
Operating cash flow: 2455208.3333333335
Depreciation & amortization: 1450000
Net tangible assets: 12970833.333333334
Owner earnings: 1757291.666666667
Return on net tangible assets (%): 13.548024413748797
Capex to operating income (%): 37.90720631786771
Buffett classification: The Good
Stock price: 3.3333333333333335
P/E ratio: 21.288365243004417
Shares outstanding: 4517125
Book value: 13282291.666666666
P/B ratio: 1.1336208924790214
Market cap (USD): 15057083.333333334
Debt to equity: 0.38655791702611564
Current ratio: 3.5814249363867687
Quick ratio: 2.01940203562341
Effective tax rate (%): 34.269119070667955
Interest coverage ratio: 5.72316384180791
COGS to revenue (%): 14.682071175577668
SG&A to revenue (%): 12.877382357901837
Free cash flow (dilution-adjusted): 2030208.3333333335
Buyback yield (%): 0
Retained earnings: 6964583.333333334
Inventory turnover: 0.3545102830380778
Receivables turnover: 58.995024875621894
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.180975044236989
FCF margin (%): 16.436161241356047
Revenue growth (%): -16.118235393740143
Rule of 40 score: 0.3179258476159035
Financial ratios for PLUT — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 13131210.191082804
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 15350000
Book value: 13625987.261146499
P/B ratio: 2.489617768595041
Market cap (USD): 33923500
Debt to equity: 0.014930256908866532
Current ratio: 6.291532881436556
Quick ratio: 6.291532881436556
Buyback yield (%): 0
Retained earnings: -3279617.834394905
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDT.L — annual report dated 2022-04-30
Total revenue: 3413750
Gross profit: 566250
Operating income: -5013750
Net income: -4202500
Capital expenditures: 35000
Operating cash flow: -2650000
Depreciation & amortization: 50000
Net tangible assets: 396250
Owner earnings: -4187500
Return on net tangible assets (%): -1056.7823343848581
Buffett classification: The Gruesome
Stock price: 0.015625
Shares outstanding: 117902876
Book value: 1777500
P/B ratio: 1.0364176863572434
Market cap (USD): 1842232.4375
Debt to equity: 0
Current ratio: 1.060819629339598
Quick ratio: 1.060819629339598
Interest coverage ratio: -91.1590909090909
COGS to revenue (%): 83.41266935188575
SG&A to revenue (%): 156.97546686195534
Free cash flow (dilution-adjusted): -4237500
Buyback yield (%): 0
Retained earnings: -30606250
Receivables turnover: 9.164429530201343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -252.26415094339623
FCF margin (%): -124.13035518125228
Rule of 40 score: -124.13035518125228
Financial ratios for RDT.L — annual report dated 2023-04-30
Total revenue: 3765000
Gross profit: 1305000
Operating income: -3453750
Net income: 465000
Capital expenditures: 7500
Operating cash flow: -3365000
Depreciation & amortization: 457500
Net tangible assets: 673750
Owner earnings: 915000
Return on net tangible assets (%): 135.80705009276437
Buffett classification: The Gruesome
Stock price: 0.004875
P/E ratio: 1.2360785387096773
Shares outstanding: 117902876
Book value: 2388750
P/B ratio: 0.24061811428571428
Market cap (USD): 574776.5205
Debt to equity: 0.05023547880690738
Current ratio: 1.234144015259895
Quick ratio: 1.234144015259895
COGS to revenue (%): 65.33864541832669
SG&A to revenue (%): 111.28818061088977
Free cash flow (dilution-adjusted): -4152500
Buyback yield (%): 0
Retained earnings: -30111250
Receivables turnover: 10.494773519163763
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -136.44444444444443
FCF margin (%): -110.29216467463479
Revenue growth (%): 10.28927132918345
Rule of 40 score: -100.00289334545134
Financial ratios for RDT.L — annual report dated 2024-04-30
Total revenue: 3567500
Gross profit: 1385000
Operating income: -4428750
Net income: -4198750
Capital expenditures: 48750
Operating cash flow: -2756250
Depreciation & amortization: 538750
Net tangible assets: -456250
Owner earnings: -3708750
Buffett classification: The Gruesome
Stock price: 0.00125
Shares outstanding: 117902876
Book value: 1568750
P/B ratio: 0.09394651474103587
Market cap (USD): 147378.595
Debt to equity: 0.26055776892430277
Current ratio: 0.9667156142927068
Quick ratio: 0.9667156142927068
Interest coverage ratio: -66.84905660377359
COGS to revenue (%): 61.17729502452698
SG&A to revenue (%): 144.4989488437281
Free cash flow (dilution-adjusted): -3730000
Buyback yield (%): 0
Retained earnings: -34185000
Receivables turnover: 7.734417344173441
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -223.95701643489252
FCF margin (%): -104.55501051156273
Revenue growth (%): -5.245683930942895
Rule of 40 score: -109.80069444250562
Financial ratios for RDT.L — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 681818.1818181818
Buffett classification: The Gruesome
Stock price: 0.0006493506493506494
Shares outstanding: 117902876
Book value: 2846753.2467532465
P/B ratio: 0.026893904197080293
Market cap (USD): 76560.3090909091
Debt to equity: 0.1747262773722628
Buyback yield (%): 0
Retained earnings: -37346753.246753246
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDT.L — annual report dated 2025-04-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00039999999999999996
Shares outstanding: 117902876
Market cap (USD): 47161.1504
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDT.L — quarterly report dated 2025-04-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00039999999999999996
Shares outstanding: 117902876
Market cap (USD): 47161.1504
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCMN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 463.42857142857144
Shares outstanding: 51801943
Market cap (USD): 24006500441.714287
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCMN.SW — annual report dated 2022-12-31
Total revenue: 12011956521.73913
Gross profit: 9883695652.173912
Operating income: 2217391304.347826
Net income: 1742391304.347826
Capital expenditures: 2471739130.4347825
Operating cash flow: 4213043478.2608695
Depreciation & amortization: 2571739130.4347825
Net tangible assets: 4625000000
Owner earnings: 1842391304.3478255
Return on net tangible assets (%): 39.835487661574604
Capex to operating income (%): 111.47058823529412
Buffett classification: The Gruesome
Stock price: 469.89130434782606
P/E ratio: 13.970043642482846
Shares outstanding: 51801943
Book value: 12142391304.347828
P/B ratio: 2.004653116005729
Market cap (USD): 24341282564.021736
Debt to equity: 0.17106794378300955
Current ratio: 0.8936367858801673
Quick ratio: 0.8560148629818858
Effective tax rate (%): 18.33927661742231
Interest coverage ratio: 16.451612903225808
COGS to revenue (%): 17.717853587910597
SG&A to revenue (%): 3.2485747896118
Free cash flow (dilution-adjusted): 1723913043.4782608
Buyback yield (%): 0
Retained earnings: 14067391304.347826
Inventory turnover: 12.08641975308642
Receivables turnover: 4.9423076923076925
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.042335335236782
FCF margin (%): 14.351642385304498
Rule of 40 score: 14.351642385304498
Financial ratios for SCMN.SW — annual report dated 2023-12-31
Total revenue: 13180952380.952381
Gross profit: 10633333333.333334
Operating income: 2625000000
Net income: 2036904761.904762
Capital expenditures: 2692857142.857143
Operating cash flow: 4796428571.428572
Depreciation & amortization: 2877380952.3809524
Net tangible assets: 5605952380.952381
Owner earnings: 2221428571.428571
Return on net tangible assets (%): 39.62624761095774
Capex to operating income (%): 102.58503401360544
Buffett classification: The Gruesome
Stock price: 533.7738095238095
P/E ratio: 13.57477333893045
Shares outstanding: 51801943
Book value: 13834523809.52381
P/B ratio: 1.9986608022467949
Market cap (USD): 27650520455.845238
Debt to equity: 0.17451165992599604
Current ratio: 0.8436578171091446
Quick ratio: 0.8071250283639665
Effective tax rate (%): 17.542168674698797
Interest coverage ratio: 16.83206106870229
COGS to revenue (%): 19.328034682080926
SG&A to revenue (%): 2.6914739884393066
Free cash flow (dilution-adjusted): 2090476190.4761906
Buyback yield (%): 0
Retained earnings: 16104761904.761906
Inventory turnover: 13.291925465838508
Receivables turnover: 5.166588894073728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.806704567731817
FCF margin (%): 15.859826589595377
Revenue growth (%): 9.731935485260982
Rule of 40 score: 25.59176207485636
Financial ratios for SCMN.SW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 607.047619047619
Shares outstanding: 51801943
Market cap (USD): 31446246160.190475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCMN.SW — annual report dated 2024-12-31
Total revenue: 12241111111.11111
Gross profit: 10211111111.11111
Operating income: 2170000000
Net income: 1713333333.3333333
Capital expenditures: 2493333333.3333335
Operating cash flow: 4874444444.444445
Depreciation & amortization: 3126666666.6666665
Net tangible assets: -545555555.5555556
Owner earnings: 2346666666.6666665
Return on net tangible assets (%): -430.142566191446
Capex to operating income (%): 114.90015360983104
Buffett classification: The Gruesome
Stock price: 517.3555555555555
P/E ratio: 15.642036770207522
Shares outstanding: 51801943
Book value: 13504444444.444447
P/B ratio: 1.9845335444841197
Market cap (USD): 26800022999.62222
Debt to equity: 0.32623004772091485
Current ratio: 0.8435526315789473
Quick ratio: 0.8078947368421052
Effective tax rate (%): 17.19505642127888
Interest coverage ratio: 9.765
COGS to revenue (%): 16.583461922483437
SG&A to revenue (%): 2.7775256421893437
Free cash flow (dilution-adjusted): 2331111111.111111
Buyback yield (%): 0
Retained earnings: 15633333333.333332
Inventory turnover: 6.74169741697417
Receivables turnover: 3.9858900144717797
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.457265663746073
FCF margin (%): 19.043296723245895
Revenue growth (%): -7.130298651252414
Rule of 40 score: 11.912998071993481
Financial ratios for SCMN.SW — quarterly report dated 2024-12-31
Total revenue: 3181111111.111111
Operating income: 332222222.2222222
Net income: 287777777.7777778
Capital expenditures: 598888888.8888888
Operating cash flow: 1126666666.6666667
Depreciation & amortization: 686666666.6666666
Net tangible assets: -545555555.5555556
Owner earnings: 375555555.5555556
Return on net tangible assets (%): -68.83910386965377
Capex to operating income (%): 180.26755852842808
Buffett classification: The Gruesome
Stock price: 517.3555555555555
P/E ratio: 23.281873262220074
Shares outstanding: 51801943
Book value: 13504444444.444447
P/B ratio: 1.9845335444841197
Market cap (USD): 26800022999.62222
Debt to equity: 0.32623004772091485
Current ratio: 0.8435526315789473
Quick ratio: 0.8078947368421052
Effective tax rate (%): 9.473684210526315
Interest coverage ratio: 4.746031746031746
COGS to revenue (%): 0
SG&A to revenue (%): 3.318197694725812
Free cash flow (dilution-adjusted): 490000000
Buyback yield (%): 0
Retained earnings: 15633333333.333332
Inventory turnover: 0
Receivables turnover: 1.0358176555716354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.988593155893536
FCF margin (%): 15.403422982885084
Rule of 40 score: 15.403422982885084
Financial ratios for SCMN.SW — quarterly report dated 2025-03-31
Total revenue: 4271590909.090909
Gross profit: 3414772727.2727275
Operating income: 589772727.2727273
Net income: 417045454.54545456
Capital expenditures: 853409090.9090909
Operating cash flow: 1889772727.2727273
Depreciation & amortization: 1326136363.6363637
Net tangible assets: 27272727.272727273
Owner earnings: 889772727.2727274
Return on net tangible assets (%): 3262.5
Capex to operating income (%): 144.70134874759154
Buffett classification: The Gruesome
Stock price: 557.3181818181818
P/E ratio: 17.3063657526703
Shares outstanding: 51801943
Book value: 14315909090.909092
P/B ratio: 2.0166490653214795
Market cap (USD): 28870164687.40909
Debt to equity: 0.3135418320368312
Current ratio: 0.852404403244496
Quick ratio: 0.8114136732329085
Effective tax rate (%): 16.968325791855204
Interest coverage ratio: 5.831460674157303
COGS to revenue (%): 20.058526203777603
SG&A to revenue (%): 2.128225591912743
Free cash flow (dilution-adjusted): 1025000000
Buyback yield (%): 0
Retained earnings: 16411363636.363636
Inventory turnover: 2.6643109540636045
Receivables turnover: 1.359985528219971
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7097677483116456
FCF margin (%): 23.995743548816176
Revenue growth (%): 34.27983996443654
Rule of 40 score: 58.27558351325271
Financial ratios for SCMN.SW — quarterly report dated 2025-06-30
Total revenue: 4608750000
Gross profit: 3716250000
Operating income: 533750000
Net income: 323750000
Capital expenditures: 870000000
Operating cash flow: 1352500000
Depreciation & amortization: 1471250000
Net tangible assets: -801250000
Owner earnings: 925000000
Return on net tangible assets (%): -115.44461778471138
Capex to operating income (%): 162.9976580796253
Buffett classification: The Gruesome
Stock price: 676.825
P/E ratio: 34.08687779263248
Shares outstanding: 51801943
Book value: 14491250000
P/B ratio: 2.419449672800828
Market cap (USD): 35060850070.975006
Debt to equity: 0.32209091693263175
Current ratio: 0.7375707055671331
Quick ratio: 0.697082465019351
Effective tax rate (%): 20.37037037037037
Interest coverage ratio: 4.542553191489362
COGS to revenue (%): 19.3653376729048
SG&A to revenue (%): 2.4410089503661516
Free cash flow (dilution-adjusted): 477500000
Buyback yield (%): 0
Retained earnings: 16945000000
Inventory turnover: 2.625
Receivables turnover: 1.3451295147756293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4628798519990407
FCF margin (%): 10.360726878220776
Revenue growth (%): 7.893056664006387
Rule of 40 score: 18.25378354222716
Financial ratios for SCMN.SW — quarterly report dated 2025-09-30
Gross profit: 3817500000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 694.8749999999999
P/E ratio: 34.995928350985096
Shares outstanding: 51801943
Market cap (USD): 35995875142.12499
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCMN.SW — annual report dated 2025-12-31
Total revenue: 19048101265.822784
Gross profit: 15232911392.405062
Operating income: 2436708860.7594934
Net income: 1608860759.4936707
Capital expenditures: 3775949367.0886073
Operating cash flow: 7610126582.278481
Depreciation & amortization: 5939240506.329114
Net tangible assets: -22784810.126582276
Owner earnings: 3772151898.734177
Return on net tangible assets (%): -16555.55555555556
Capex to operating income (%): 154.96103896103898
Buffett classification: The Gruesome
Stock price: 701.2278481012659
P/E ratio: 22.578066375853663
Shares outstanding: 51801943
Book value: 15491139240.506329
P/B ratio: 2.344886612494689
Market cap (USD): 36324965017.35443
Debt to equity: 0.3047066514136297
Current ratio: 0.7599288678126852
Quick ratio: 0.7319205690574985
Effective tax rate (%): 18.953414167198467
Interest coverage ratio: 5.31767955801105
COGS to revenue (%): 20.029239766081872
SG&A to revenue (%): 2.5451887293992557
Free cash flow (dilution-adjusted): 3801265822.78481
Buyback yield (%): 0
Retained earnings: 17994936708.86076
Inventory turnover: 15.947089947089948
Receivables turnover: 6.117073170731707
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.575576430401366
FCF margin (%): 19.956140350877195
Revenue growth (%): 55.6076167671826
Rule of 40 score: 75.5637571180598
Financial ratios for SCMN.SW — quarterly report dated 2025-12-31
Total revenue: 4902531645.56962
Gross profit: 3800000000
Operating income: 556962025.3164557
Net income: 356962025.31645566
Capital expenditures: 1096202531.6455696
Operating cash flow: 2117721518.9873416
Depreciation & amortization: 1491139240.506329
Net tangible assets: -22784810.126582276
Owner earnings: 751898734.1772151
Return on net tangible assets (%): -3300
Capex to operating income (%): 196.8181818181818
Buffett classification: The Gruesome
Stock price: 701.2278481012659
P/E ratio: 33.09015486910993
Shares outstanding: 51801943
Book value: 15491139240.506329
P/B ratio: 2.344886612494689
Market cap (USD): 36324965017.35443
Debt to equity: 0.3047066514136297
Current ratio: 0.7599288678126852
Quick ratio: 0.7319205690574985
Effective tax rate (%): 19.65811965811966
Interest coverage ratio: 4.631578947368422
COGS to revenue (%): 22.489026594371285
SG&A to revenue (%): 3.1758326878388843
Free cash flow (dilution-adjusted): 1016455696.2025316
Buyback yield (%): 0
Retained earnings: 17994936708.86076
Inventory turnover: 4.608465608465608
Receivables turnover: 1.574390243902439
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5029888983774553
FCF margin (%): 20.733281693777432
Rule of 40 score: 20.733281693777432
Financial ratios for SDEV — annual report dated 2021-12-31
Gross profit: 6515000
Capital expenditures: 52000
Buffett classification: The Gruesome
Stock price: 1538.52
Shares outstanding: 27115646
Market cap (USD): 41717963683.92
Buyback yield (%): 0
Inventory turnover: 1.1456521739130434
Capitalized R&D asset: 44000
Rule of 40 score: 0
Financial ratios for SDEV — annual report dated 2022-12-31
Total revenue: 14404000
Gross profit: 7781000
Operating income: -7680000
Net income: -10608000
Capital expenditures: 112000
Operating cash flow: -6654000
Depreciation & amortization: 483000
Net tangible assets: 7926000
Owner earnings: -10237000
Return on net tangible assets (%): -129.1572041382791
Buffett classification: The Gruesome
Stock price: 225.57
Shares outstanding: 27115646
Book value: 10554000
P/B ratio: 579.5410525127913
Market cap (USD): 6116476268.22
Debt to equity: 0.19338639378434716
Current ratio: 2.661968522433639
Quick ratio: 1.8545924359877848
COGS to revenue (%): 45.98028325465149
R&D to revenue (%): 1.2079977783948903
SG&A to revenue (%): 106.13024159955569
Free cash flow (dilution-adjusted): -6986000
Buyback yield (%): 0
Retained earnings: -158152000
Inventory turnover: 1.9269711958102997
Receivables turnover: 7.14484126984127
Capitalized R&D asset: 203480
ROCI (R&D-adjusted, %): -61.38818957761599
Rosenberg metric: 28.772727272727273
FCF margin (%): -48.50041655095807
Rule of 40 score: -48.50041655095807
Financial ratios for SDEV — annual report dated 2023-12-31
Total revenue: 10455000
Gross profit: 6084000
Operating income: -4102000
Net income: -9640000
Capital expenditures: 19000
Operating cash flow: -4261000
Depreciation & amortization: 356000
Net tangible assets: 3314000
Owner earnings: -9303000
Return on net tangible assets (%): -280.71816535908266
Buffett classification: The Gruesome
Stock price: 23.14
Shares outstanding: 27115646
Book value: 3314000
P/B ratio: 189.33495728424865
Market cap (USD): 627456048.44
Debt to equity: 0.7884731442365721
Current ratio: 1.6722767648433847
Quick ratio: 1.451846657316503
Interest coverage ratio: -2.4214876033057853
COGS to revenue (%): 41.8077474892396
R&D to revenue (%): 0.3252032520325203
SG&A to revenue (%): 97.10186513629843
Free cash flow (dilution-adjusted): -4571000
Buyback yield (%): 0
Retained earnings: -174849000
Inventory turnover: 4.635206786850477
Receivables turnover: 13.666666666666666
Capitalized R&D asset: 165100
ROCI (R&D-adjusted, %): -84.37138038243482
Rosenberg metric: -9.75287356321839
FCF margin (%): -43.720707795313245
Revenue growth (%): -27.41599555678978
Rule of 40 score: -71.13670335210303